Asceneuron (Switzerland)
We are a passionate team of scientists and drug developers dedicated to improving the lives of patients affected by neurodegenerative diseases, such as Alzheimers, Parkinsons and orphan taupathies. Asceneuron discovers and develops groundbreaking therapeutics for neurodegenerative disorders with high unmet medical needs: orphan tauopathies, Alzheimer’s and Parkinson’s diseases.
Basic Information
- Category: business
- Website: http://www.asceneuron.com/
Documented Facts
- Inception (Wikidata): 2012 (Source 2: Wikidata Q30264415, revision 2474419160)
- Country (Wikidata; date unspecified): Switzerland (Source 2: Wikidata Q30264415, revision 2474419160; Source 3: Wikidata label: Q39, revision 2550802861)
- Official website (Wikidata; date unspecified): http://www.asceneuron.com/ (Source 2: Wikidata Q30264415, revision 2474419160)
Evidence and Sources
- Asceneuron (Switzerland) — Official Website (official)
- Wikidata Q30264415, revision 2474419160 (knowledge-base)
- Wikidata label: Q39, revision 2550802861 (knowledge-base)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Asceneuron (Switzerland).
- Canonical profile: https://brandsource.ai/brands/asceneuron-switzerland
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/asceneuron-switzerland/json-ld
- Citation profile API: https://brandsource.ai/api/brands/asceneuron-switzerland/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (91/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
We are a passionate team of scientists and drug developers dedicated to improving the lives of patients affected by neurodegenerative diseases, such as Alzheimers, Parkinsons and orphan taupathies. Asceneuron discovers and develops groundbreaking therapeutics for neurodegenerative disorders with high unmet medical needs: orphan tauopathies, Alzheimer’s and Parkinson’s diseases.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
- 3 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.